Thu.Jul 04, 2024

article thumbnail

Whitepaper: Precision medicine and the role of ecosystems

Drug Discovery World

A new whitepaper is now available to download for free from Bruntwood SciTech. This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems , examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech.

Science 130
article thumbnail

Scientists discover new T cells and genes related to immune disorders

Science Daily: Pharmacology News

Researchers have discovered several rare types of helper T cells that are associated with immune disorders such as multiple sclerosis, rheumatoid arthritis, and even asthma. The discoveries were made possible by a newly developed technology they call ReapTEC. The new T cell atlas is publicly available and should help in the development of new drug therapies for immune-mediated diseases.

Therapies 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fuelling the future: Precision medicine innovation and the role of ecosystems

Drug Discovery World

This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems , examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper, you will discover: The evolution of precision diagnostics for oncology in the North West of England How life science ecosystems enable key breakthroug

Science 100
article thumbnail

About 1 in 8 Americans Has Been Diagnosed With Chronic Insomnia

Drugs.com

FRIDAY, July 4, 2024 -- Millions of Americans struggle to fall or stay asleep, a new survey finds. Some struggle more mightily than others: Roughly 12% of Americans polled said they have been diagnosed with chronic insomnia, the American Academy of.

104
104
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

The dawn of the Antarctic ice sheets

Science Daily: Pharmacology News

In recent years global warming has left its mark on the Antarctic ice sheets. The 'eternal' ice in Antarctica is melting faster than previously assumed, particularly in West Antarctica more than East Antarctica. The root for this could lie in its formation, as an international research team has now discovered: sediment samples from drill cores combined with complex climate and ice-sheet modelling show that permanent glaciation of Antarctica began around 34 million years ago -- but did not encomp

article thumbnail

Unsafe Neighborhoods Could Drive Up Smoking Rates

Drugs.com

THURSDAY, July 4, 2024 -- It may sound far-fetched, but new research suggests that living in dangerous neighborhoods could trigger an unintended health harm: higher smoking rates among residents. "High levels of neighborhood threat shape.

More Trending

article thumbnail

Tips to Staying Germ-Free at the Gym

Drugs.com

THURSDAY, July 4, 2024 -- Going to the gym is good for your overall health, but if you and the gym aren't practicing good hygiene you could still catch a nasty illness, an expert says. “Good hygiene prevents sicknesses like a cold, influenza.

52
article thumbnail

Aldehyde oxidase-mediated DDI

Metabolite Tales Blog

First-ever identification of an aldehyde oxidase-mediated DDI Inhibition of aldehyde oxidase mediated metabolism of OS1-930 by erlotinib Where metabolic pathways have not been interrogated for drugs in development, unwelcome surprises may arise. Scientists at Pfizer recently uncovered a major role for aldehyde oxidase in the metabolism of quinoline-containing OSI-930, and demonstrated an aldehyde oxidase-mediated DDI (drug-drug interaction) arising from inhibition of the enzyme by erlotinib (Tan

Drugs 52
article thumbnail

When Bills Become an Issue, Couples Stop Communicating

Drugs.com

FRIDAY, July 4, 2024 -- If you and your partner fall silent when vexing money issues arise, new research suggests you are not alone. A team from Cornell University found that the more stressed people were about their finances, the less likely they.

article thumbnail

CDISC Standards for Biostatistics and Clinical Data Management

ProRelix Research

Collating and integrating data from a myriad of sources especially in global clinical trials requires that the data be in an accurate, reliable, and consistent format. The application of standards […] The post CDISC Standards for Biostatistics and Clinical Data Management appeared first on ProRelix Research.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Which pharmaceutical companies have the most gas dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most gas dosed drugs. For a different perspective, see the most popular dosage types.

article thumbnail

FlexCards in Salesforce OmniStudio: A Beginner’s Guide

Perficient: Drug Development

Introduction FlexCards in Salesforce OmniStudio are powerful components designed to display data from multiple sources in a visually appealing and customizable manner. They provide a way to consolidate information and present it in a single, unified view, making it easier for users to interact with and understand complex data. Build industry-specific UI components and applications on the Salesforce platform with OmniStudio FlexCards.

52